A New Partnership Could Boost This $1 Stock
Titan Pharmaceuticals, Inc. (Nasdaq: TTNP) is up on news after announcing the execution of a specialty pharmacy distribution and services agreement with AllianceRx Walgreens Prime that will expand patient access to treatment with Probuphine (buprenorphine) implant, Titan's unique six-month maintenance treatment for opioid use disorder...